- Version
- Download 6
- File Size 4.00 KB
- File Count 1
- Create Date July 5, 2023
- Last Updated February 15, 2024
D9.4 Second Risk Management Report - Executive Summary
GLOMICAVE is Research and Innovation Action developed by 15 partners across 6 countries. Naturally, there is a wide variety of risks in the project due to the involvement of many partners in the design and development tasks as well as the multidisciplinary nature of the consortium. Also, the COVID-19 situation brought new risks that must be monitored and dealt with. This document describes the risks involved in the project, building upon previous D9.3, and the plans for mitigation and contingency in the case that risks actually happened.